• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现 8 种原发性视网膜母细胞瘤中共有的转录组核心基因,并进行了新的检测评分分析。

Discovery of a transcriptomic core of genes shared in 8 primary retinoblastoma with a novel detection score analysis.

机构信息

Medical Research Unit in Infectious Diseases, Hospital de Pediatría, CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Pharmacology Department, CINVESTAV, Mexico City, Mexico.

出版信息

J Cancer Res Clin Oncol. 2020 Aug;146(8):2029-2040. doi: 10.1007/s00432-020-03266-y. Epub 2020 May 30.

DOI:10.1007/s00432-020-03266-y
PMID:32474753
Abstract

PURPOSE

Expression microarrays are powerful technology that allows large-scale analysis of RNA profiles in a tissue; these platforms include underexploited detection scores outputs. We developed an algorithm using the detection score, to generate a detection profile of shared elements in retinoblastoma as well as to determine its transcriptomic size and structure.

METHODS

We analyzed eight briefly cultured primary retinoblastomas with the Human transcriptome array 2.0 (HTA2.0). Transcripts and genes detection scores were determined using the Detection Above Background algorithm (DABG). We used unsupervised and supervised computational tools to analyze detected and undetected elements; WebGestalt was used to explore functions encoded by genes in relevant clusters and performed experimental validation.

RESULTS

We found a core cluster with 7,513 genes detected and shared by all samples, 4,321 genes in a cluster that was commonly absent, and 7,681 genes variably detected across the samples accounting for tumor heterogeneity. Relevant pathways identified in the core cluster relate to cell cycle, RNA transport, and DNA replication. We performed a kinome analysis of the core cluster and found 4 potential therapeutic kinase targets. Through analysis of the variably detected genes, we discovered 123 differentially expressed transcripts between bilateral and unilateral cases.

CONCLUSIONS

This novel analytical approach allowed determining the retinoblastoma transcriptomic size, a shared active transcriptomic core among the samples, potential therapeutic target kinases shared by all samples, transcripts related to inter tumor heterogeneity, and to determine transcriptomic profiles without the need of control tissues. This approach is useful to analyze other cancer or tissue types.

摘要

目的

表达微阵列是一种强大的技术,可允许对组织中的 RNA 谱进行大规模分析;这些平台包括利用不足的检测分数输出。我们开发了一种使用检测分数的算法,以生成视网膜母细胞瘤中共享元素的检测谱,并确定其转录组大小和结构。

方法

我们使用人类转录组阵列 2.0(HTA2.0)分析了 8 个短暂培养的原发性视网膜母细胞瘤。使用检测超过背景算法(DABG)确定转录物和基因的检测分数。我们使用无监督和有监督的计算工具来分析检测到和未检测到的元素;使用 WebGestalt 探索相关簇中基因编码的功能,并进行实验验证。

结果

我们发现了一个核心簇,其中包含 7513 个基因,这些基因在所有样本中均被检测到并共享,在一个共同缺失的簇中包含 4321 个基因,在跨样本的可变检测中包含 7681 个基因,这些基因共同构成了肿瘤异质性。核心簇中鉴定出的相关途径与细胞周期、RNA 转运和 DNA 复制有关。我们对核心簇进行了激酶组分析,发现了 4 个潜在的治疗激酶靶标。通过对可变检测基因的分析,我们在双侧和单侧病例之间发现了 123 个差异表达的转录本。

结论

这种新的分析方法允许确定视网膜母细胞瘤转录组的大小、样本之间共享的活跃转录组核心、所有样本共享的潜在治疗性激酶靶标、与肿瘤间异质性相关的转录本,以及无需对照组织即可确定转录组谱。这种方法可用于分析其他癌症或组织类型。

相似文献

1
Discovery of a transcriptomic core of genes shared in 8 primary retinoblastoma with a novel detection score analysis.发现 8 种原发性视网膜母细胞瘤中共有的转录组核心基因,并进行了新的检测评分分析。
J Cancer Res Clin Oncol. 2020 Aug;146(8):2029-2040. doi: 10.1007/s00432-020-03266-y. Epub 2020 May 30.
2
Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them?视网膜母细胞瘤存活患者的继发性骨肉瘤的临床表现是否与常规骨肉瘤不同,我们应如何检测?
Clin Orthop Relat Res. 2023 Nov 1;481(11):2154-2163. doi: 10.1097/CORR.0000000000002667. Epub 2023 May 5.
3
Cytogenetics and cytology of retinoblastomas.视网膜母细胞瘤的细胞遗传学与细胞学
J Cancer Res Clin Oncol. 2003 Feb;129(2):89-99. doi: 10.1007/s00432-003-0414-1. Epub 2003 Feb 26.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
8
Artificial intelligence for diagnosing exudative age-related macular degeneration.人工智能在渗出性年龄相关性黄斑变性诊断中的应用。
Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2.
9
Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test.接受cfDNA检测的视网膜母细胞瘤患者中RB1嵌合体的检测与特征分析
JAMA Ophthalmol. 2025 May 8. doi: 10.1001/jamaophthalmol.2025.1079.
10
Single-cell analysis comparing early-stage oocytes from fresh and slow-frozen/thawed human ovarian cortex reveals minimal impact of cryopreservation on the oocyte transcriptome.单细胞分析比较新鲜和慢速冷冻/解冻的人类卵巢皮质中的早期卵母细胞,结果显示冷冻保存对卵母细胞转录组的影响极小。
Hum Reprod. 2025 Apr 1;40(4):683-694. doi: 10.1093/humrep/deaf009.

引用本文的文献

1
Gene expression study in retinoblastoma patients with different anaplasias and lateralities.不同间变程度和发病侧别的视网膜母细胞瘤患者的基因表达研究。
Sci Rep. 2025 Mar 22;15(1):9925. doi: 10.1038/s41598-025-94225-5.
2
Identification of dysregulation of sphingolipids in retinoblastoma using liquid chromatography-mass spectrometry.采用液相色谱-质谱联用技术鉴定视网膜母细胞瘤中鞘脂的失调。
Exp Eye Res. 2024 Mar;240:109798. doi: 10.1016/j.exer.2024.109798. Epub 2024 Jan 19.
3
Genetics in ophthalmology: molecular blueprints of retinoblastoma.

本文引用的文献

1
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.WebGestalt 2019:基因集分析工具包,具有全新的用户界面和 API。
Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205. doi: 10.1093/nar/gkz401.
2
Properties of FDA-approved small molecule protein kinase inhibitors.已批准用于临床的小分子蛋白激酶抑制剂的特性。
Pharmacol Res. 2019 Jun;144:19-50. doi: 10.1016/j.phrs.2019.03.006. Epub 2019 Mar 13.
3
Comparison of RNA-seq and microarray platforms for splice event detection using a cross-platform algorithm.使用跨平台算法比较 RNA-seq 和微阵列平台在剪接事件检测中的性能。
眼科学遗传学:视网膜母细胞瘤的分子蓝图。
Hum Genomics. 2023 Sep 1;17(1):82. doi: 10.1186/s40246-023-00529-w.
4
Clinical Applications of Machine Learning in the Management of Intraocular Cancers: A Narrative Review.机器学习在眼内肿瘤管理中的临床应用:叙事性综述。
Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):29. doi: 10.1167/iovs.64.10.29.
5
Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies.视网膜母细胞瘤:肿瘤发生的分子基础及其临床相关性综述,为未来的靶向治疗策略提供指导。
Indian J Ophthalmol. 2023 Jul;71(7):2662-2676. doi: 10.4103/IJO.IJO_3172_22.
BMC Genomics. 2018 Sep 25;19(1):703. doi: 10.1186/s12864-018-5082-2.
4
Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes.基于通路的乳腺癌分子亚型药物重新定位
Front Pharmacol. 2018 Aug 15;9:905. doi: 10.3389/fphar.2018.00905. eCollection 2018.
5
Retinoblastoma, the visible CNS tumor: A review.视网膜母细胞瘤,可见的中枢神经系统肿瘤:综述。
J Neurosci Res. 2019 Jan;97(1):29-44. doi: 10.1002/jnr.24213. Epub 2018 Jan 3.
6
Cancer transcriptome profiling at the juncture of clinical translation.癌症转录组谱分析在临床转化的交汇点。
Nat Rev Genet. 2018 Feb;19(2):93-109. doi: 10.1038/nrg.2017.96. Epub 2017 Dec 27.
7
miRNome landscape analysis reveals a 30 miRNA core in retinoblastoma.微小RNA组景观分析揭示了视网膜母细胞瘤中的一个由30个微小RNA组成的核心。
BMC Cancer. 2017 Jul 1;17(1):458. doi: 10.1186/s12885-017-3421-3.
8
Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.视网膜母细胞瘤中光感受器功能丧失和基因组改变增加揭示了肿瘤进展。
EBioMedicine. 2015 Jul 8;2(7):660-70. doi: 10.1016/j.ebiom.2015.06.022. eCollection 2015 Jul.
9
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.用于临床终点预测的RNA测序和基于微阵列模型的比较。
Genome Biol. 2015 Jun 25;16(1):133. doi: 10.1186/s13059-015-0694-1.
10
Ten things you should know about protein kinases: IUPHAR Review 14.关于蛋白激酶你应该了解的十件事:IUPHAR综述14
Br J Pharmacol. 2015 Jun;172(11):2675-700. doi: 10.1111/bph.13096. Epub 2015 Mar 24.